Last updated: 15 December 2023 at 6:47pm EST

Todd Simpson Net Worth




The estimated Net Worth of Todd E Simpson is at least $61.2 Milhão dollars as of 21 September 2023. Mr. Simpson owns over 80 units of Seagen Inc stock worth over $29,459,546 and over the last 19 years he sold SGEN stock worth over $27,293,535. In addition, he makes $4,490,090 as Chief Financial Officer at Seagen Inc.

Mr. Simpson SGEN stock SEC Form 4 insiders trading

Todd has made over 54 trades of the Seagen Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he sold 80 units of SGEN stock worth $16,520 on 21 September 2023.

The largest trade he's ever made was exercising 95,000 units of Seagen Inc stock on 5 September 2012 worth over $1,109,600. On average, Todd trades about 14,620 units every 53 days since 2005. As of 21 September 2023 he still owns at least 128,723 units of Seagen Inc stock.

You can see the complete history of Mr. Simpson stock trades at the bottom of the page.





Todd Simpson biography

Todd E. Simpson CPA serves as Chief Financial Officer of the Company. Previously, Mr. Simpson served from October 2001 to October 2005 as Vice President, Finance & Administration and Chief Financial Officer of Targeted Genetics Corporation, a biotechnology company. From January 1996 to October 2001, Mr. Simpson served as Vice President, Finance & Administration and CFO of Aastrom Biosciences, Inc., a biotechnology company. From August 1995 to December 1995, he served as Treasurer of Integra LifeSciences Corporation, a biotechnology company, which acquired Telios Pharmaceuticals, Inc., in August 1995. From 1992 until its acquisition by Integra, he served as Vice President of Finance and CFO of Telios and in various other finance-related positions. Mr. Simpson is a certified public accountant (inactive), and from 1983 to 1992 he practiced public accounting with the firm of Ernst & Young LLP. Mr. Simpson currently serves on the board of directors of Neoleukin Therapeutics, Inc., a publicly-traded biotechnology company. Mr. Simpson received a B.S. in Accounting and Computer Science from Oregon State University.

What is the salary of Todd Simpson?

As the Chief Financial Officer of Seagen Inc, the total compensation of Todd Simpson at Seagen Inc is $4,490,090. There are 2 executives at Seagen Inc getting paid more, with Clay Siegall having the highest compensation of $14,521,500.



How old is Todd Simpson?

Todd Simpson is 59, he's been the Chief Financial Officer of Seagen Inc since 2005. There are 9 older and 8 younger executives at Seagen Inc. The oldest executive at Seagen Inc is Marc Lippman, 75, who is the Independent Director.

Insiders trading at Seagen Inc

Over the last 22 years, insiders at Seagen Inc have traded over $729,924,224 worth of Seagen Inc stock and bought 35,347,908 units worth $1,433,871,526 . The most active insiders traders include Bros. Advisors Lp667, L.P.B..., Felixbaker Julian Baker Bro..., eBrothers Life Sciences Capi.... On average, Seagen Inc executives and independent directors trade stock every 8 days with the average trade being worth of $18,157,295. The most recent stock trade was executed by David R Epstein on 10 November 2023, trading 10,620 units of SGEN stock currently worth $2,262,166.



What does Seagen Inc do?

seattle genetics, co-founded by clay siegall, is a biotechnology company leading the field of antibody-drug conjugates (adcs) for the treatment of cancer. our technology is designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. our lead program, adcetris® (brentuximab vedotin), is the first in a new class of adcs and, in collaboration with takeda pharmaceutical company limited, is approved in more than 55 countries. to expand on the adcetris opportunity, we are conducting a broad clinical development program to evaluate its therapeutic potential in a range of other lymphoma and non-lymphoma settings. seattle genetics is also advancing a robust pipeline of clinical-stage programs, including sgn-cd19a, sgn-cd33a, sgn-liv1a, sgn-cd70a, asg-22me, asg-15me and sea-cd40. seattle genetics has collaborations for its adc technology with a number of leading biotechnology and pharmaceutical companies, including abbvie, agensys



Complete history of Mr. Simpson stock trades at Seagen Inc e Neoleukin Therapeutics

Acionista maioritário
Trans.
Transação
Preço total
Todd E Simpson
Diretor Financeiro
Venda $16,520
21 Sep 2023
Todd E Simpson
Diretor Financeiro
Venda $439,190
31 Aug 2023
Todd E Simpson
Diretor Financeiro
Venda $99,910
28 Aug 2023
Todd E Simpson
Diretor Financeiro
Exercício de opção $2,566,301
10 Apr 2023
Todd E Simpson
Diretor Financeiro
Venda $50,024
5 Apr 2023
Todd E Simpson
Diretor Financeiro
Exercício de opção $1,938,523
9 Mar 2023
Todd E Simpson
Diretor Financeiro
Venda $3,650,600
27 Feb 2023
Todd E Simpson
Diretor Financeiro
Exercício de opção $1,563,886
16 Feb 2023
Todd E Simpson
Diretor Financeiro
Venda $646,360
31 Aug 2022
Todd E Simpson
Diretor Financeiro
Venda $334,823
15 Aug 2022
Todd E Simpson
Diretor Financeiro
Venda $81,829
20 Apr 2022
Todd E Simpson
Diretor Financeiro
Venda $51,698
20 Dec 2021
Todd E Simpson
Diretor Financeiro
Exercício de opção $1,873,973
3 Nov 2021
Todd E Simpson
Diretor Financeiro
Exercício de opção $1,377,467
29 Oct 2021
Todd E Simpson
Diretor Financeiro
Venda $667,902
31 Aug 2021
Todd E Simpson
Diretor Financeiro
Venda $82,375
16 Aug 2021
Todd E Simpson
Diretor Financeiro
Exercício de opção $928,787
18 Dec 2020
Todd E Simpson
Diretor Financeiro
Venda $1,354,398
5 Nov 2020
Todd E Simpson
Diretor Financeiro
Venda $2,536,438
31 Aug 2020
Todd E Simpson
Diretor Financeiro
Venda $1,464,971
18 Aug 2020
Todd E Simpson
Diretor Financeiro
Venda $3,314,400
3 Aug 2020
Todd E Simpson
Diretor Financeiro
Venda $1,939,403
1 Jul 2020
Todd E Simpson
Diretor Financeiro
Exercício de opção $1,035,246
4 May 2020
Todd E Simpson
Diretor Financeiro
Venda $1,275,000
30 Sep 2019
Todd E Simpson
Diretor Financeiro
Venda $148,114
30 Aug 2019
Todd E Simpson
Diretor Financeiro
Venda $432,598
28 Aug 2019
Todd E Simpson
Diretor Financeiro
Venda $1,000,000
20 Aug 2019
Todd E Simpson
Diretor Financeiro
Venda $975,000
5 Apr 2019
Todd E Simpson
Diretor Financeiro
Venda $750,000
4 Mar 2019
Todd E Simpson
Diretor Financeiro
Venda $402,846
27 Aug 2018
Todd E Simpson
Diretor Financeiro
Venda $2,398,940
1 Nov 2017
Todd E Simpson
Diretor Financeiro
Venda $501,176
6 Sep 2017
Todd E Simpson
Diretor Financeiro
Venda $236,433
28 Aug 2017
Todd E Simpson
Diretor Financeiro
Venda $185,941
22 Aug 2016
Todd E Simpson
Diretor Financeiro
Venda $185,941
22 Aug 2016
Todd E Simpson
Diretor Financeiro
Exercício de opção $199,962
29 Sep 2015
Todd E Simpson
Diretor Financeiro
Venda $244,767
20 Aug 2015
Todd E Simpson
Diretor Financeiro
Venda $160,961
24 Aug 2014
Todd E Simpson
Diretor Financeiro
Exercício de opção $1,155,468
27 Aug 2013
Todd E Simpson
Diretor Financeiro
Venda $136,148
19 Aug 2013
Todd E Simpson
Diretor Financeiro
Exercício de opção $1,211,178
11 Jul 2013
Todd E Simpson
Diretor Financeiro
Venda $1,528,829
7 Mar 2013
Todd E Simpson
Diretor Financeiro
Exercício de opção $378,232
8 Nov 2012
Todd E Simpson
Diretor Financeiro
Exercício de opção $1,109,600
5 Sep 2012
Todd E Simpson
Diretor Financeiro
Exercício de opção $473,400
24 Aug 2012
Todd E Simpson
Diretor Financeiro
Exercício de opção $411,600
16 Aug 2012
Todd E Simpson
Diretor Financeiro
Exercício de opção $502,550
12 Jun 2012
Todd E Simpson
Diretor Financeiro
Exercício de opção $182,000
8 Jun 2012
Todd E Simpson
Diretor Financeiro
Exercício de opção $126,620
7 Oct 2011
Todd E Simpson
Diretor Financeiro
Exercício de opção $86,410
18 Jul 2011
Todd E Simpson
Diretor Financeiro
Exercício de opção $55,900
7 Jun 2011
Todd E Simpson
Diretor Financeiro
Exercício de opção $105,188
18 May 2011
Todd E Simpson
Diretor Financeiro
Exercício de opção $89,000
9 May 2011
Todd E Simpson
Diretor Financeiro
Exercício de opção $66,750
29 Apr 2011


Seagen Inc executives and stock owners

Seagen Inc executives and other stock owners filed with the SEC include: